Eton Pharmaceuticals, Inc. ETON Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eton Pharmaceuticals, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s change in AP?
- Eton Pharmaceuticals, Inc. (ETON) reported change in AP of $2.51M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s change in AP changed year-over-year?
- Eton Pharmaceuticals, Inc.'s change in AP increased by 255.7% year-over-year, from $705K to $2.51M.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s change in AP?
- Over 2 years (2021 to 2024), Eton Pharmaceuticals, Inc.'s change in AP has grown at a 107.2% compound annual growth rate (CAGR), from -$570K to $2.45M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.